Strides Pharma Science inks pact with MPP to market COVID-19 drug | Business - Devdiscourse

Retrieved on: 2022-03-21 07:18:36

Tags for this article:

Health sciences

Chemical compounds

Health care

COVID-19 drug development

Pfizer

Nirmatrelvir

Ritonavir

Pharmaceutical industry

Medicines Patent Pool

Nirmatrelvir/ritonavir

Dr. Reddy's Laboratories

Strides Pharma

Click the tags to see associated articles and topics

Strides Pharma Science inks pact with MPP to market COVID-19 drug | Business - Devdiscourse. View article details on HISWAI: https://www.devdiscourse.com/article/business/1969891-strides-pharma-science-inks-pact-with-mpp-to-market-covid-19-drug

Excerpt

Strides Pharma Science on Monday said it has inked a sub-license agreement with Medicines Patent Pool to commercialise a generic version of Pfizer's ...

Article found on: www.devdiscourse.com

View Original Article